ArticleMolecular therapy oncolytics2020

CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease.

Constanze Slabik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.